These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
451 related articles for article (PubMed ID: 28253859)
1. A genetic variant in long non-coding RNA MALAT1 associated with survival outcome among patients with advanced lung adenocarcinoma: a survival cohort analysis. Wang JZ; Xiang JJ; Wu LG; Bai YS; Chen ZW; Yin XQ; Wang Q; Guo WH; Peng Y; Guo H; Xu P BMC Cancer; 2017 Mar; 17(1):167. PubMed ID: 28253859 [TBL] [Abstract][Full Text] [Related]
2. The associations of TERT-CLPTM1L variants and TERT mRNA expression with the prognosis of early stage non-small cell lung cancer. Chen Z; Wang J; Bai Y; Wang S; Yin X; Xiang J; Li X; He M; Zhang X; Wu T; Xu P; Guo H Cancer Gene Ther; 2017 Jan; 24(1):20-27. PubMed ID: 27982019 [TBL] [Abstract][Full Text] [Related]
3. The genetic variations in DNA repair genes ERCC2 and XRCC1 were associated with the overall survival of advanced non-small-cell lung cancer patients. Wang S; Wang J; Bai Y; Wang Q; Liu L; Zhang K; Hong X; Deng Q; Zhang X; He M; Wu T; Xu P; Guo H Cancer Med; 2016 Sep; 5(9):2332-42. PubMed ID: 27465648 [TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA MALAT1 polymorphism predicts MACCEs in patients with myocardial infarction. Zhang T; Luo JY; Liu F; Zhang XH; Luo F; Yang YN; Li XM BMC Cardiovasc Disord; 2022 Apr; 22(1):152. PubMed ID: 35392816 [TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA polymorphisms and prediction of response to chemotherapy based on irinotecan in patients with metastatic colorectal cancer. Lampropoulou DI; Aravantinos G; Katifelis H; Lazaris F; Laschos K; Theodosopoulos T; Papadimitriou C; Gazouli M Cancer Biomark; 2019; 25(2):213-221. PubMed ID: 31045514 [TBL] [Abstract][Full Text] [Related]
6. Role of EGFR SNPs in survival of advanced lung adenocarcinoma patients treated with Gefitinib. Zhang L; Yuan X; Chen Y; Du XJ; Yu S; Yang M Gene; 2013 Mar; 517(1):60-4. PubMed ID: 23313300 [TBL] [Abstract][Full Text] [Related]
7. Association between genetic variants in pre-microRNAs and survival of early-stage NSCLC. Hong MJ; Choi YY; Jang JA; Jung HJ; Lee SY; Lee WK; Yoo SS; Lee J; Cha SI; Kim CH; Lee E; Jeon HS; Son JW; Park JY J Thorac Oncol; 2013 Jun; 8(6):703-10. PubMed ID: 23470291 [TBL] [Abstract][Full Text] [Related]
8. Correlation of increased MALAT1 expression with pathological features and prognosis in cancer patients: a meta-analysis. Shi XS; Li J; Yang RH; Zhao GR; Zhou HP; Zeng WX; Zhou M Genet Mol Res; 2015 Dec; 14(4):18808-19. PubMed ID: 26782531 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the clinical significance of long non-coding RNA Lin SH; Lu JW; Hsieh WT; Chou YE; Su TC; Tsai TJ; Tsai YJ; Yang PJ; Yang SF Aging (Albany NY); 2024 Mar; 16(6):5740-5750. PubMed ID: 38517388 [TBL] [Abstract][Full Text] [Related]
10. Development of a novel prognostic signature of long non-coding RNAs in lung adenocarcinoma. Zheng S; Zheng D; Dong C; Jiang J; Xie J; Sun Y; Chen H J Cancer Res Clin Oncol; 2017 Sep; 143(9):1649-1657. PubMed ID: 28409273 [TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA ROR is a novel prognosis factor associated with non-small-cell lung cancer progression. Qu CH; Sun QY; Zhang FM; Jia YM Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4087-4091. PubMed ID: 29028092 [TBL] [Abstract][Full Text] [Related]
12. A circulating non-coding RNA panel as an early detection predictor of non-small cell lung cancer. Peng H; Wang J; Li J; Zhao M; Huang SK; Gu YY; Li Y; Sun XJ; Yang L; Luo Q; Huang CZ Life Sci; 2016 Apr; 151():235-242. PubMed ID: 26946307 [TBL] [Abstract][Full Text] [Related]
13. MALAT1 Polymorphisms and Lung Cancer Susceptibility in a Chinese Northeast Han Population. Tong G; Tong W; He R; Cui Z; Li S; Zhou B; Yin Z Int J Med Sci; 2022; 19(8):1300-1306. PubMed ID: 35928715 [No Abstract] [Full Text] [Related]
14. Association of GSTP1 and XRCC1 gene polymorphisms with clinical outcome of advanced non-small cell lung cancer patients with cisplatin-based chemotherapy. Han B; Guo Z; Ma Y; Kang S; Wang Y; Wei Q; Wu X Int J Clin Exp Pathol; 2015; 8(4):4113-9. PubMed ID: 26097600 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival. He LR; Ma NF; Chen JW; Li BK; Guan XY; Liu MZ; Xie D Oncotarget; 2015 Oct; 6(31):31181-90. PubMed ID: 26360781 [TBL] [Abstract][Full Text] [Related]
16. The up-regulation of long non-coding RNA AFAP1-AS1 is associated with the poor prognosis of NSCLC patients. Deng J; Liang Y; Liu C; He S; Wang S Biomed Pharmacother; 2015 Oct; 75():8-11. PubMed ID: 26463625 [TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA VPS9D1-AS1 overexpression predicts a poor prognosis in non-small cell lung cancer. Tan J; Yang L Biomed Pharmacother; 2018 Oct; 106():1600-1606. PubMed ID: 30119235 [TBL] [Abstract][Full Text] [Related]
18. The lncRNA MALAT1 is a novel biomarker for gastric cancer metastasis. Xia H; Chen Q; Chen Y; Ge X; Leng W; Tang Q; Ren M; Chen L; Yuan D; Zhang Y; Liu M; Gong Q; Bi F Oncotarget; 2016 Aug; 7(35):56209-56218. PubMed ID: 27486823 [TBL] [Abstract][Full Text] [Related]
19. Survival outcome according to KRAS mutation status in newly diagnosed patients with stage IV non-small cell lung cancer treated with platinum doublet chemotherapy. Brady AK; McNeill JD; Judy B; Bauml J; Evans TL; Cohen RB; Langer C; Vachani A; Aggarwal C Oncotarget; 2015 Oct; 6(30):30287-94. PubMed ID: 26471290 [TBL] [Abstract][Full Text] [Related]
20. Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study. Lee Y; Yoon KA; Joo J; Lee D; Bae K; Han JY; Lee JS Carcinogenesis; 2013 Feb; 34(2):307-13. PubMed ID: 23144319 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]